Anti-complement factor H autoantibodies may be protective in lupus nephritis

Area of Science:

• Immunology
• Nephrology
• Complement System

Background:

• Lupus nephritis is a severe complication of Systemic Lupus Erythematosus (SLE).
• The role of autoantibodies against complement factor H (anti-CFH) in lupus nephritis pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the prevalence and role of anti-CFH autoantibodies in a cohort of patients with lupus nephritis.
• To characterize the epitopes and IgG subclasses of anti-CFH autoantibodies.
• To assess the functional impact of anti-CFH autoantibodies on complement factor H activity.

Main Methods:

• ELISA and Western blot were used to detect anti-CFH autoantibodies and their epitopes.
• Purification of autoantibodies via affinity chromatography.
• In vitro assays (C3b binding and cofactor activity) to study the functional effects of purified autoantibodies.

Main Results:

• Anti-CFH autoantibodies were detected in 8.3% of lupus nephritis patients, significantly higher than in healthy controls.
• The predominant subclass was IgG2, with major epitopes in the middle and N-terminal regions of CFH.
• Patients with anti-CFH autoantibodies showed significantly lower rates of acute kidney injury, lower serum creatinine, and higher hemoglobin levels.
• Purified anti-CFH autoantibodies enhanced CFH's C3b binding and cofactor activity in vitro.

Conclusions:

• Anti-CFH autoantibodies are present in a subset of lupus nephritis patients.
• These autoantibodies are associated with milder renal damage and appear to enhance CFH function.
• The findings suggest a potential protective role for anti-CFH autoantibodies in lupus nephritis.